Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Formulations for trans-tympanic antibiotic delivery.

Khoo X, Simons EJ, Chiang HH, Hickey JM, Sabharwal V, Pelton SI, Rosowski JJ, Langer R, Kohane DS.

Biomaterials. 2013 Jan;34(4):1281-8. doi: 10.1016/j.biomaterials.2012.10.025. Epub 2012 Nov 9.

2.

Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment.

Al-Mahallawi AM, Khowessah OM, Shoukri RA.

Int J Pharm. 2014 Sep 10;472(1-2):304-14. doi: 10.1016/j.ijpharm.2014.06.041. Epub 2014 Jun 24.

PMID:
24971692
3.

Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study.

Antonelli PJ, Winterstein AG, Schultz GS.

Otol Neurotol. 2010 Apr;31(3):519-23. doi: 10.1097/MAO.0b013e3181ca85cc.

PMID:
20010446
4.

OTO-201: nonclinical assessment of a sustained-release ciprofloxacin hydrogel for the treatment of otitis media.

Wang X, Fernandez R, Tsivkovskaia N, Harrop-Jones A, Hou HJ, Dellamary L, Dolan DF, Altschuler RA, LeBel C, Piu F.

Otol Neurotol. 2014 Mar;35(3):459-69. doi: 10.1097/MAO.0000000000000261.

5.

Ciprofloxacin 0.3% + dexamethasone 0.1% for the treatment for otitis media.

Kutz JW Jr, Roland PS, Lee KH.

Expert Opin Pharmacother. 2013 Dec;14(17):2399-405. doi: 10.1517/14656566.2013.844789. Epub 2013 Oct 7. Review.

PMID:
24093464
6.

Auditory function after a prolonged course of ciprofloxacin-dexamethasone otic suspension in a murine model.

Kavanagh KR, Parham K, Schoem SR.

Arch Otolaryngol Head Neck Surg. 2009 Mar;135(3):238-41. doi: 10.1001/archoto.2008.559.

PMID:
19289700
7.

Morphological changes in the tympanic membrane associated with Haemophilus influenzae-induced acute otitis media in the chinchilla.

Guan X, Jiang S, Seale TW, Hitt BM, Gan RZ.

Int J Pediatr Otorhinolaryngol. 2015 Sep;79(9):1462-71. doi: 10.1016/j.ijporl.2015.06.030. Epub 2015 Jun 29.

PMID:
26183006
8.

In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.

Ong HX, Benaouda F, Traini D, Cipolla D, Gonda I, Bebawy M, Forbes B, Young PM.

Eur J Pharm Biopharm. 2014 Jan;86(1):83-9. doi: 10.1016/j.ejpb.2013.06.024. Epub 2013 Jul 10.

PMID:
23851077
9.

Factors affecting loss of tympanic membrane mobility in acute otitis media model of chinchilla.

Guan X, Chen Y, Gan RZ.

Hear Res. 2014 Mar;309:136-46. doi: 10.1016/j.heares.2013.12.005. Epub 2014 Jan 7.

10.

Dynamic Properties of Tympanic Membrane in a Chinchilla Otitis Media Model Measured With Acoustic Loading.

Yokell Z, Wang X, Gan RZ.

J Biomech Eng. 2015 Aug;137(8):081006. doi: 10.1115/1.4030410. Epub 2015 Jun 9.

11.

Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella.

Gnanadhas DP, Ben Thomas M, Elango M, Raichur AM, Chakravortty D.

J Antimicrob Chemother. 2013 Nov;68(11):2576-86. doi: 10.1093/jac/dkt252. Epub 2013 Jun 24.

PMID:
23798672
12.

Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies.

Al-Mahallawi AM, Khowessah OM, Shoukri RA.

Int J Pharm. 2017 Mar 7;522(1-2):157-164. doi: 10.1016/j.ijpharm.2017.03.005. [Epub ahead of print]

PMID:
28279741
13.

Treatment of otitis media by transtympanic delivery of antibiotics.

Yang R, Sabharwal V, Okonkwo OS, Shlykova N, Tong R, Lin LY, Wang W, Guo S, Rosowski JJ, Pelton SI, Kohane DS.

Sci Transl Med. 2016 Sep 14;8(356):356ra120. doi: 10.1126/scitranslmed.aaf4363.

PMID:
27629487
14.

Ototopic applications of povidone iodine/dexamethasone in the rat.

Pawlowski K, Koulich E, Wright CG, Roland P.

Otol Neurotol. 2013 Jan;34(1):167-74. doi: 10.1097/MAO.0b013e31827a21a2.

PMID:
23202157
15.

Study of the distribution of oral ciprofloxacin into the mucosa of the middle ear and the cortical bone of the mastoid process.

Massias L, Buffe P, Cohen B, Cudennec Y, Gehanno P, Sterkers O, Farinotti R.

Chemotherapy. 1994;40 Suppl 1:3-7.

PMID:
7805429
16.

Alpha1-antitrypsin single dose adjuvant therapy for acute otitis media.

Antonelli PJ, Schultz GS, Sundin DJ, Pemberton PA, Barr PJ.

Otolaryngol Head Neck Surg. 2006 Jul;135(1):111-5.

PMID:
16815194
17.

Absorption of intratympanic topical antibiotics.

Becvarovski Z.

Ear Nose Throat J. 2004 Sep;83(9 Suppl 4):18-9. Review. No abstract available.

PMID:
15543838
18.

Acute otitis media disease management.

Pichichero ME, Casey JR.

Minerva Pediatr. 2003 Oct;55(5):415-38. Review.

PMID:
14608265
19.

Effects of ciprofloxacin/dexamethasone and ofloxacin on tympanic membrane perforation healing.

Buyten J, Kaufman G, Ryan M.

Otol Neurotol. 2007 Oct;28(7):887-90.

PMID:
17955604
20.

Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.

Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, Fazeli MR, Jamalifar H.

J Microencapsul. 2010;27(7):618-27. doi: 10.3109/02652048.2010.506579.

PMID:
20681747

Supplemental Content

Support Center